TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.9400
-0.0350 (-3.59%)
Oct 19, 2026, 11:48 AM EDT - Market open
TELA Bio Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, TELA Bio stock has a consensus rating of "Buy" and an average price target of $2.08. The average 1-year stock price forecast is 121.28% higher than the current stock price, while the lowest is $1.00 (+6.38%) and the highest is $3.00 (+219.15%).
Price Target: $2.08 (+121.28%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TELA Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Mar '26 | May '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $2 | Buy | Reiterates | $2 | +112.77% | Sep 30, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Initiates $2 | Buy | Initiates | $2 | +112.77% | Sep 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2 | Buy | Maintains | $2 | +112.77% | Sep 1, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $1 | Hold | Maintains | $1 | +6.38% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
79.59M
from 80.28M
Decreased by -0.86%
Revenue Next Year
86.94M
from 79.59M
Increased by 9.24%
EPS This Year
-0.69
from -0.83
EPS Next Year
-0.45
from -0.69
EPS and Forward PE are based on non-GAAP adjusted numbers.